National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

This is VAERS ID 412367

Government Disclaimer on use of this data

History of Changes from the VAERS Wayback Machine

First Appeared on 12/7/2010

VAERS ID: 412367
VAERS Form:
Age:11.0
Sex:Female
Location:South Carolina
Vaccinated:2010-07-23
Onset:2010-07-25
Submitted:2010-10-22
Entered:2010-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA088BC / 0 RA / IM

Administered by: Public      Purchased by: Public
Symptoms: Dermatitis atopic, Injection site pruritus, Injection site reaction

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Cetirizine hydrochloride
Current Illness: Allergic rhinitis
Preexisting Conditions: Seasonal allergy. There were no concomitant vaccinations. The subject had not experienced adverse events following previous vaccinations.
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': A0873007A

Write-up: This case was reported by a physician and described the occurrence of atopic dermatitis in a 11-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included seasonal allergy. Concurrent medications included ZYRTEC. On 23 July 2010 the subject received 1st dose of CERVARIX (.5 ml, unknown route, right arm). On 25 July 2010, 2 days after vaccination with CERVARIX, the subject experienced atopic dermatitis and itching near injection site. The atopic dermatitis and itching occurred on the area above the deltoid on the same arm as she received the vaccination. At the time of reporting the events were improved. The vaccination course with CERVARIX was discontinued. The physician considered the events were possibly related to vaccination with CERVARIX. Follow-up information was received on 17 August 2010. It was reported that the events began on 25 July 2010 and resolved by 01 August 2010. Medical history of seasonal allergies began on 17 December 2002 and continues. It was reported that CERVARIX was given intramuscularly in the right deltoid. Concurrent ZYRTEC was taken orally at 10 mg daily beginning on 17 December 2002 for allergic rhinitis and allergies.


Changed on 6/14/2014

VAERS ID: 412367 Before After
VAERS Form:
Age:11.0
Sex:Female
Location:South Carolina
Vaccinated:2010-07-23
Onset:2010-07-25
Submitted:2010-10-22
Entered:2010-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA088BC / 0 RA / IM

Administered by: Public      Purchased by: Public
Symptoms: Dermatitis atopic, Injection site pruritus, Injection site reaction

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Cetirizine hydrochloride
Current Illness: Allergic rhinitis
Preexisting Conditions: Seasonal allergy. There were no concomitant vaccinations. The subject had not experienced adverse events following previous vaccinations.
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': A0873007A

Write-up: This case was reported by a physician and described the occurrence of atopic dermatitis in a 11-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included seasonal allergy. Concurrent medications included ZYRTEC. On 23 July 2010 the subject received 1st dose of CERVARIX (.5 ml, unknown route, right arm). On 25 July 2010, 2 days after vaccination with CERVARIX, the subject experienced atopic dermatitis and itching near injection site. The atopic dermatitis and itching occurred on the area above the deltoid on the same arm as she received the vaccination. At the time of reporting the events were improved. The vaccination course with CERVARIX was discontinued. The physician considered the events were possibly related to vaccination with CERVARIX. Follow-up information was received on 17 August 2010. It was reported that the events began on 25 July 2010 and resolved by 01 August 2010. Medical history of seasonal allergies began on 17 December 2002 and continues. It was reported that CERVARIX was given intramuscularly in the right deltoid. Concurrent ZYRTEC was taken orally at 10 mg daily beginning on 17 December 2002 for allergic rhinitis and allergies.


Changed on 4/14/2017

VAERS ID: 412367 Before After
VAERS Form:
Age:11.0
Sex:Female
Location:South Carolina
Vaccinated:2010-07-23
Onset:2010-07-25
Submitted:2010-10-22
Entered:2010-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA088BC / 0 RA / IM

Administered by: Public      Purchased by: Public
Symptoms: Dermatitis atopic, Injection site pruritus, Injection site reaction

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Cetirizine hydrochloride
Current Illness: Allergic rhinitis
Preexisting Conditions: Seasonal allergy. There were no concomitant vaccinations. The subject had not experienced adverse events following previous vaccinations.
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': A0873007A

Write-up: This case was reported by a physician and described the occurrence of atopic dermatitis in a 11-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included seasonal allergy. Concurrent medications included ZYRTEC. On 23 July 2010 the subject received 1st dose of CERVARIX (.5 ml, unknown route, right arm). On 25 July 2010, 2 days after vaccination with CERVARIX, the subject experienced atopic dermatitis and itching near injection site. The atopic dermatitis and itching occurred on the area above the deltoid on the same arm as she received the vaccination. At the time of reporting the events were improved. The vaccination course with CERVARIX was discontinued. The physician considered the events were possibly related to vaccination with CERVARIX. Follow-up information was received on 17 August 2010. It was reported that the events began on 25 July 2010 and resolved by 01 August 2010. Medical history of seasonal allergies began on 17 December 2002 and continues. It was reported that CERVARIX was given intramuscularly in the right deltoid. Concurrent ZYRTEC was taken orally at 10 mg daily beginning on 17 December 2002 for allergic rhinitis and allergies.


Changed on 9/14/2017

VAERS ID: 412367 Before After
VAERS Form:(blank) 1
Age:11.0
Sex:Female
Location:South Carolina
Vaccinated:2010-07-23
Onset:2010-07-25
Submitted:2010-10-22
Entered:2010-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA088BC / 0 1 RA / IM

Administered by: Public      Purchased by: Public
Symptoms: Dermatitis atopic, Injection site pruritus, Injection site reaction

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Cetirizine hydrochloride
Current Illness: Allergic rhinitis
Preexisting Conditions: Seasonal allergy. There were no concomitant vaccinations. The subject had not experienced adverse events following previous vaccinations.
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': A0873007A

Write-up: This case was reported by a physician and described the occurrence of atopic dermatitis in a 11-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included seasonal allergy. Concurrent medications included ZYRTEC. On 23 July 2010 the subject received 1st dose of CERVARIX (.5 ml, unknown route, right arm). On 25 July 2010, 2 days after vaccination with CERVARIX, the subject experienced atopic dermatitis and itching near injection site. The atopic dermatitis and itching occurred on the area above the deltoid on the same arm as she received the vaccination. At the time of reporting the events were improved. The vaccination course with CERVARIX was discontinued. The physician considered the events were possibly related to vaccination with CERVARIX. Follow-up information was received on 17 August 2010. It was reported that the events began on 25 July 2010 and resolved by 01 August 2010. Medical history of seasonal allergies began on 17 December 2002 and continues. It was reported that CERVARIX was given intramuscularly in the right deltoid. Concurrent ZYRTEC was taken orally at 10 mg daily beginning on 17 December 2002 for allergic rhinitis and allergies.


Changed on 2/14/2018

VAERS ID: 412367 Before After
VAERS Form:1
Age:11.0
Sex:Female
Location:South Carolina
Vaccinated:2010-07-23
Onset:2010-07-25
Submitted:2010-10-22
Entered:2010-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA088BC / 1 RA / IM

Administered by: Public      Purchased by: Public
Symptoms: Dermatitis atopic, Injection site pruritus, Injection site reaction

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Cetirizine hydrochloride
Current Illness: Allergic rhinitis
Preexisting Conditions: Seasonal allergy. There were no concomitant vaccinations. The subject had not experienced adverse events following previous vaccinations.
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': A0873007A

Write-up: This case was reported by a physician and described the occurrence of atopic dermatitis in a 11-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included seasonal allergy. Concurrent medications included ZYRTEC. On 23 July 2010 the subject received 1st dose of CERVARIX (.5 ml, unknown route, right arm). On 25 July 2010, 2 days after vaccination with CERVARIX, the subject experienced atopic dermatitis and itching near injection site. The atopic dermatitis and itching occurred on the area above the deltoid on the same arm as she received the vaccination. At the time of reporting the events were improved. The vaccination course with CERVARIX was discontinued. The physician considered the events were possibly related to vaccination with CERVARIX. Follow-up information was received on 17 August 2010. It was reported that the events began on 25 July 2010 and resolved by 01 August 2010. Medical history of seasonal allergies began on 17 December 2002 and continues. It was reported that CERVARIX was given intramuscularly in the right deltoid. Concurrent ZYRTEC was taken orally at 10 mg daily beginning on 17 December 2002 for allergic rhinitis and allergies.


Changed on 6/14/2018

VAERS ID: 412367 Before After
VAERS Form:1
Age:11.0
Sex:Female
Location:South Carolina
Vaccinated:2010-07-23
Onset:2010-07-25
Submitted:2010-10-22
Entered:2010-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA088BC / 1 RA / IM

Administered by: Public      Purchased by: Public
Symptoms: Dermatitis atopic, Injection site pruritus, Injection site reaction

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Cetirizine hydrochloride
Current Illness: Allergic rhinitis
Preexisting Conditions: Seasonal allergy. There were no concomitant vaccinations. The subject had not experienced adverse events following previous vaccinations.
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': A0873007A

Write-up: This case was reported by a physician and described the occurrence of atopic dermatitis in a 11-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included seasonal allergy. Concurrent medications included ZYRTEC. On 23 July 2010 the subject received 1st dose of CERVARIX (.5 ml, unknown route, right arm). On 25 July 2010, 2 days after vaccination with CERVARIX, the subject experienced atopic dermatitis and itching near injection site. The atopic dermatitis and itching occurred on the area above the deltoid on the same arm as she received the vaccination. At the time of reporting the events were improved. The vaccination course with CERVARIX was discontinued. The physician considered the events were possibly related to vaccination with CERVARIX. Follow-up information was received on 17 August 2010. It was reported that the events began on 25 July 2010 and resolved by 01 August 2010. Medical history of seasonal allergies began on 17 December 2002 and continues. It was reported that CERVARIX was given intramuscularly in the right deltoid. Concurrent ZYRTEC was taken orally at 10 mg daily beginning on 17 December 2002 for allergic rhinitis and allergies.


Changed on 8/14/2018

VAERS ID: 412367 Before After
VAERS Form:1
Age:11.0
Sex:Female
Location:South Carolina
Vaccinated:2010-07-23
Onset:2010-07-25
Submitted:2010-10-22
Entered:2010-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA088BC / 1 RA / IM

Administered by: Public      Purchased by: Public
Symptoms: Dermatitis atopic, Injection site pruritus, Injection site reaction

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Cetirizine hydrochloride
Current Illness: Allergic rhinitis
Preexisting Conditions: Seasonal allergy. There were no concomitant vaccinations. The subject had not experienced adverse events following previous vaccinations.
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': A0873007A

Write-up: This case was reported by a physician and described the occurrence of atopic dermatitis in a 11-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included seasonal allergy. Concurrent medications included ZYRTEC. On 23 July 2010 the subject received 1st dose of CERVARIX (.5 ml, unknown route, right arm). On 25 July 2010, 2 days after vaccination with CERVARIX, the subject experienced atopic dermatitis and itching near injection site. The atopic dermatitis and itching occurred on the area above the deltoid on the same arm as she received the vaccination. At the time of reporting the events were improved. The vaccination course with CERVARIX was discontinued. The physician considered the events were possibly related to vaccination with CERVARIX. Follow-up information was received on 17 August 2010. It was reported that the events began on 25 July 2010 and resolved by 01 August 2010. Medical history of seasonal allergies began on 17 December 2002 and continues. It was reported that CERVARIX was given intramuscularly in the right deltoid. Concurrent ZYRTEC was taken orally at 10 mg daily beginning on 17 December 2002 for allergic rhinitis and allergies.


Changed on 9/14/2018

VAERS ID: 412367 Before After
VAERS Form:1
Age:11.0
Sex:Female
Location:South Carolina
Vaccinated:2010-07-23
Onset:2010-07-25
Submitted:2010-10-22
Entered:2010-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA088BC / 1 RA / IM

Administered by: Public      Purchased by: Public
Symptoms: Dermatitis atopic, Injection site pruritus, Injection site reaction

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Cetirizine hydrochloride
Current Illness: Allergic rhinitis
Preexisting Conditions: Seasonal allergy. There were no concomitant vaccinations. The subject had not experienced adverse events following previous vaccinations.
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': A0873007A

Write-up: This case was reported by a physician and described the occurrence of atopic dermatitis in a 11-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included seasonal allergy. Concurrent medications included ZYRTEC. On 23 July 2010 the subject received 1st dose of CERVARIX (.5 ml, unknown route, right arm). On 25 July 2010, 2 days after vaccination with CERVARIX, the subject experienced atopic dermatitis and itching near injection site. The atopic dermatitis and itching occurred on the area above the deltoid on the same arm as she received the vaccination. At the time of reporting the events were improved. The vaccination course with CERVARIX was discontinued. The physician considered the events were possibly related to vaccination with CERVARIX. Follow-up information was received on 17 August 2010. It was reported that the events began on 25 July 2010 and resolved by 01 August 2010. Medical history of seasonal allergies began on 17 December 2002 and continues. It was reported that CERVARIX was given intramuscularly in the right deltoid. Concurrent ZYRTEC was taken orally at 10 mg daily beginning on 17 December 2002 for allergic rhinitis and allergies.


Changed on 10/14/2018

VAERS ID: 412367 Before After
VAERS Form:1
Age:11.0
Sex:Female
Location:South Carolina
Vaccinated:2010-07-23
Onset:2010-07-25
Submitted:2010-10-22
Entered:2010-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA088BC / 1 RA / IM

Administered by: Public      Purchased by: Public
Symptoms: Dermatitis atopic, Injection site pruritus, Injection site reaction

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Cetirizine hydrochloride
Current Illness: Allergic rhinitis
Preexisting Conditions: Seasonal allergy. There were no concomitant vaccinations. The subject had not experienced adverse events following previous vaccinations.
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': A0873007A

Write-up: This case was reported by a physician and described the occurrence of atopic dermatitis in a 11-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included seasonal allergy. Concurrent medications included ZYRTEC. On 23 July 2010 the subject received 1st dose of CERVARIX (.5 ml, unknown route, right arm). On 25 July 2010, 2 days after vaccination with CERVARIX, the subject experienced atopic dermatitis and itching near injection site. The atopic dermatitis and itching occurred on the area above the deltoid on the same arm as she received the vaccination. At the time of reporting the events were improved. The vaccination course with CERVARIX was discontinued. The physician considered the events were possibly related to vaccination with CERVARIX. Follow-up information was received on 17 August 2010. It was reported that the events began on 25 July 2010 and resolved by 01 August 2010. Medical history of seasonal allergies began on 17 December 2002 and continues. It was reported that CERVARIX was given intramuscularly in the right deltoid. Concurrent ZYRTEC was taken orally at 10 mg daily beginning on 17 December 2002 for allergic rhinitis and allergies.


Changed on 12/24/2020

VAERS ID: 412367 Before After
VAERS Form:1
Age:11.0
Sex:Female
Location:South Carolina
Vaccinated:2010-07-23
Onset:2010-07-25
Submitted:2010-10-22
Entered:2010-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA088BC / 1 RA / IM

Administered by: Public      Purchased by: Public
Symptoms: Dermatitis atopic, Injection site pruritus, Injection site reaction

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Cetirizine hydrochloride
Current Illness: Allergic rhinitis
Preexisting Conditions: Seasonal allergy. There were no concomitant vaccinations. The subject had not experienced adverse events following previous vaccinations.
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': A0873007A

Write-up: This case was reported by a physician and described the occurrence of atopic dermatitis in a 11-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included seasonal allergy. Concurrent medications included ZYRTEC. On 23 July 2010 the subject received 1st dose of CERVARIX (.5 ml, unknown route, right arm). On 25 July 2010, 2 days after vaccination with CERVARIX, the subject experienced atopic dermatitis and itching near injection site. The atopic dermatitis and itching occurred on the area above the deltoid on the same arm as she received the vaccination. At the time of reporting the events were improved. The vaccination course with CERVARIX was discontinued. The physician considered the events were possibly related to vaccination with CERVARIX. Follow-up information was received on 17 August 2010. It was reported that the events began on 25 July 2010 and resolved by 01 August 2010. Medical history of seasonal allergies began on 17 December 2002 and continues. It was reported that CERVARIX was given intramuscularly in the right deltoid. Concurrent ZYRTEC was taken orally at 10 mg daily beginning on 17 December 2002 for allergic rhinitis and allergies.


Changed on 12/30/2020

VAERS ID: 412367 Before After
VAERS Form:1
Age:11.0
Sex:Female
Location:South Carolina
Vaccinated:2010-07-23
Onset:2010-07-25
Submitted:2010-10-22
Entered:2010-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA088BC / 1 RA / IM

Administered by: Public      Purchased by: Public
Symptoms: Dermatitis atopic, Injection site pruritus, Injection site reaction

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Cetirizine hydrochloride
Current Illness: Allergic rhinitis
Preexisting Conditions: Seasonal allergy. There were no concomitant vaccinations. The subject had not experienced adverse events following previous vaccinations.
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': A0873007A

Write-up: This case was reported by a physician and described the occurrence of atopic dermatitis in a 11-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included seasonal allergy. Concurrent medications included ZYRTEC. On 23 July 2010 the subject received 1st dose of CERVARIX (.5 ml, unknown route, right arm). On 25 July 2010, 2 days after vaccination with CERVARIX, the subject experienced atopic dermatitis and itching near injection site. The atopic dermatitis and itching occurred on the area above the deltoid on the same arm as she received the vaccination. At the time of reporting the events were improved. The vaccination course with CERVARIX was discontinued. The physician considered the events were possibly related to vaccination with CERVARIX. Follow-up information was received on 17 August 2010. It was reported that the events began on 25 July 2010 and resolved by 01 August 2010. Medical history of seasonal allergies began on 17 December 2002 and continues. It was reported that CERVARIX was given intramuscularly in the right deltoid. Concurrent ZYRTEC was taken orally at 10 mg daily beginning on 17 December 2002 for allergic rhinitis and allergies.


Changed on 5/7/2021

VAERS ID: 412367 Before After
VAERS Form:1
Age:11.0
Sex:Female
Location:South Carolina
Vaccinated:2010-07-23
Onset:2010-07-25
Submitted:2010-10-22
Entered:2010-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA088BC / 1 RA / IM

Administered by: Public      Purchased by: Public
Symptoms: Dermatitis atopic, Injection site pruritus, Injection site reaction

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Cetirizine hydrochloride
Current Illness: Allergic rhinitis
Preexisting Conditions: Seasonal allergy. There were no concomitant vaccinations. The subject had not experienced adverse events following previous vaccinations.
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': A0873007A

Write-up: This case was reported by a physician and described the occurrence of atopic dermatitis in a 11-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included seasonal allergy. Concurrent medications included ZYRTEC. On 23 July 2010 the subject received 1st dose of CERVARIX (.5 ml, unknown route, right arm). On 25 July 2010, 2 days after vaccination with CERVARIX, the subject experienced atopic dermatitis and itching near injection site. The atopic dermatitis and itching occurred on the area above the deltoid on the same arm as she received the vaccination. At the time of reporting the events were improved. The vaccination course with CERVARIX was discontinued. The physician considered the events were possibly related to vaccination with CERVARIX. Follow-up information was received on 17 August 2010. It was reported that the events began on 25 July 2010 and resolved by 01 August 2010. Medical history of seasonal allergies began on 17 December 2002 and continues. It was reported that CERVARIX was given intramuscularly in the right deltoid. Concurrent ZYRTEC was taken orally at 10 mg daily beginning on 17 December 2002 for allergic rhinitis and allergies.


Changed on 5/21/2021

VAERS ID: 412367 Before After
VAERS Form:1
Age:11.0
Sex:Female
Location:South Carolina
Vaccinated:2010-07-23
Onset:2010-07-25
Submitted:2010-10-22
Entered:2010-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS AHPVA088BC / 1 RA / IM

Administered by: Public      Purchased by: Public
Symptoms: Dermatitis atopic, Injection site pruritus, Injection site reaction

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Cetirizine hydrochloride
Current Illness: Allergic rhinitis
Preexisting Conditions: Seasonal allergy. There were no concomitant vaccinations. The subject had not experienced adverse events following previous vaccinations.
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': A0873007A

Write-up: This case was reported by a physician and described the occurrence of atopic dermatitis in a 11-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). The subject''s medical history included seasonal allergy. Concurrent medications included ZYRTEC. On 23 July 2010 the subject received 1st dose of CERVARIX (.5 ml, unknown route, right arm). On 25 July 2010, 2 days after vaccination with CERVARIX, the subject experienced atopic dermatitis and itching near injection site. The atopic dermatitis and itching occurred on the area above the deltoid on the same arm as she received the vaccination. At the time of reporting the events were improved. The vaccination course with CERVARIX was discontinued. The physician considered the events were possibly related to vaccination with CERVARIX. Follow-up information was received on 17 August 2010. It was reported that the events began on 25 July 2010 and resolved by 01 August 2010. Medical history of seasonal allergies began on 17 December 2002 and continues. It was reported that CERVARIX was given intramuscularly in the right deltoid. Concurrent ZYRTEC was taken orally at 10 mg daily beginning on 17 December 2002 for allergic rhinitis and allergies.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=412367&WAYBACKHISTORY=ON


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166